glp-1 agonists vision loss blindness Ozempic Lawsuit [2026 Update] The question everyone is asking.
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Richards JR, Dorand MF, Royal K, Mnajjed L, Paszkowiak M, Simmons WK
This surge pushed annual spending by this group from an average of $1.6 billion between 2018-2021 to $5.8 billion in 2022
![glp-1 agonists vision loss blindness Ozempic Lawsuit [2026 Update] The question everyone is asking.](https://res.cloudinary.com/broadcastmed/image/fetch/q_auto,f_auto,dpr_auto/https://www.glaucomaphysician.net/media/30hgcds4/pg15_fig1_sept25.jpg)
In the event of persistence, in spite of compliance with these and the other guidelines, probiotic and/or antidiarrheal supplements such as loperamide could be considered [29]
Beard, E
There is evidence from a previous meta-analysis that GLP-1RA confer a similar reduction in MACE in both sexes, whereas SGLT-2 inhibitors reduce the risk of MACE more in men than in women [31]
![glp-1 agonists vision loss blindness Ozempic Lawsuit [2026 Update] The question everyone is asking.](https://assets.newsweek.com/wp-content/uploads/2026/07/GLP-1-medications-linked-to-risk-of-sudden-vision-loss.png?w=1600&h=900&q=88)